Life Sciences

Researchers have pinpointed three previously unknown genetic variants that increase colorectal cancer risk by analyzing patterns across multiple cancer types. The discovery could improve genetic screening and help doctors identify high-risk patients earlier, potentially reducing treatment costs and improving outcomes for a disease that affects over 1 million people annually worldwide.EN

Blind individuals process gentle and discriminative touch more effectively than sighted people, according to new research. The finding could inform rehabilitation programs, assistive technology design, and our understanding of sensory adaptation—areas where disability-informed innovation is increasingly recognized as a competitive advantage.EN

Type 2 diabetes doesn't just affect blood sugar—it actively damages the digestive system, a major new analysis reveals. The finding could reshape how doctors treat millions of diabetic patients and opens opportunities for companies developing gastrointestinal therapies targeting this overlooked complication.EN

Swedish researchers found that having a first-degree relative with inflammatory bowel disease substantially increases colorectal cancer risk, even in relatives without IBD themselves. The finding could reshape screening protocols and preventive strategies for millions of families worldwide, with major implications for healthcare systems and insurance models.EN

Researchers found that disgusting odors trigger immune defenses in the oral cavity, suggesting the body uses smell as an early warning system. The discovery could reshape how we understand immune priming and may have implications for food safety, infection prevention, and designing healthier food products.EN

Patients with inborn errors of immunity face significantly elevated risk of developing non-blood cancers, a new clinical analysis reveals. The finding could reshape screening protocols and treatment strategies for this vulnerable population, with implications for pharmaceutical development and healthcare resource allocation.EN

A Swedish study of female healthcare employees found that night work correlates with increased breast cancer risk, raising occupational health concerns for hospitals and clinics. The finding could influence scheduling policies and worker screening programs across the healthcare industry.EN

Researchers identified a cellular mechanism in Langerhans cell histiocytosis—a rare blood disorder—where abnormal myeloid cells activate natural killer immune cells through changes in how they release proteins. The finding could guide development of targeted treatments for a disease that currently lacks effective therapies and primarily affects children.EN

Researchers mapped how a common cellular enzyme protects against dangerous reactive molecules produced during normal metabolism. The finding could unlock new drug targets for diseases tied to metabolic stress, from cancer to neurodegeneration, and improve how companies design therapies that exploit or mimic this protective mechanism.EN

Researchers in Southeast China have developed a risk assessment tool that blends genetic markers with lifestyle factors to predict breast cancer susceptibility. The approach could help insurers, healthcare systems, and pharmaceutical companies better stratify patients and personalize prevention strategies in an underserved population.EN

Researchers have demonstrated that synthetic DNA and protein molecules can prevent the repetitive genetic mutations that cause Friedreich's ataxia, a devastating inherited neurological disorder. The finding, published in Nucleic Acids Research, opens a potential treatment pathway for a rare disease with no cure—and validates a molecular strategy that could apply to other repeat-expansion disorders affecting thousands of patients.EN

Researchers found that a specific form of a common protein helps stabilize dangerous arterial plaques and reduces heart attack risk. The discovery could lead to new treatments targeting heart disease, the leading cause of death globally, and may reshape how doctors assess which patients face the greatest cardiovascular danger.EN

A new study reveals that autism and ADHD share common genetic factors that increase risk for multiple co-occurring physical health conditions—findings that could reshape how clinicians screen and treat these neurodevelopmental disorders. Understanding these genetic links may help identify which patients need preventive care earlier, reducing costly complications.EN

Researchers characterized a cohort of Iranian patients with DCLRE1C gene defects, a rare condition that cripples the immune system. The findings could help clinicians identify and manage the disease earlier, potentially improving outcomes for affected families and informing genetic screening policies.EN

A new study shows that Alzheimer's disease risk genes and high inflammation (measured by C-reactive protein) each separately erode cognitive ability in older adults. The finding matters because it suggests treatment strategies may need to target both pathways simultaneously—not just genes or just inflammation alone—to slow cognitive decline.EN

Researchers have developed a faster way to analyze extracellular vesicles—tiny particles circulating in blood that carry disease signals—using electrical charges instead of traditional chemical labels. The advance could accelerate diagnosis of cancers and other conditions, reducing testing time and costs for clinical labs and diagnostic companies.EN

Researchers tracked over 1,000 digital nerve injury cases in Sweden to establish incidence rates and rehabilitation outcomes—data that has been missing from health systems. The findings could reshape how hospitals allocate resources for hand trauma care and inform workplace safety standards across Europe.EN

Researchers have demonstrated a new way to control gene expression by editing the 3' UTR—a regulatory region that acts like a dimmer switch for genes—directly in living animals. This approach could enable more precise treatments for genetic diseases and offer pharmaceutical companies a novel way to modulate disease-driving genes without permanently altering DNA.EN

The International Society for Cell & Gene Therapy convened experts to assess therapeutic potential of extracellular vesicles—tiny cell-derived particles being developed as drug delivery vehicles and treatments. The findings could reshape how companies approach next-generation cell therapies and influence regulatory decisions on what counts as a viable treatment modality.EN

Researchers discovered that the connections between brain metabolism and the default mode network—the brain's resting state activity—operate differently in people with autism. The finding could eventually help develop better diagnostic tools and personalized treatments for autism spectrum disorder, a condition affecting roughly 1 in 36 children.EN

Scientists have identified galectin-3 as a driver of neural dysfunction in Alzheimer's disease, specifically how it disrupts the brain's electrical synchronization critical for memory and cognition. The finding opens a new therapeutic avenue for a protein that could be drugged, potentially slowing cognitive decline before irreversible brain damage occurs.EN

Researchers found that high levels of FGF11 protein correlate with poor survival outcomes in patients with HPV-positive oropharyngeal cancer. The discovery could enable doctors to identify high-risk patients earlier and tailor treatment strategies, potentially improving outcomes for a cancer type increasingly common in younger adults.EN

Researchers fed healthy volunteers surstromming—a pungent Swedish fermented fish—and tracked changes to their gut microbiome, a finding with potential implications for probiotic products and personalized nutrition markets. The work suggests fermented foods may alter microbial populations in measurable ways, opening doors for food companies and health startups seeking evidence-based claims about digestive health benefits.EN

A comprehensive overview of genotyping methods helps laboratories and biotech firms navigate competing technologies for DNA analysis. The review clarifies trade-offs between speed, cost, and accuracy—critical for companies developing diagnostics, precision medicine tools, and agricultural genomics applications.EN

Researchers have developed a highly sensitive blood test that can simultaneously identify multiple genetic mutations in medulloblastoma, an aggressive childhood brain cancer. The advance could enable earlier diagnosis and more personalized treatment decisions, potentially improving survival rates and reducing the need for invasive biopsies.EN